A team in Germany is planning to launch a trial with the drug IMU-838 trial for Long Covid. Currently there aren’t too many details on the trial, however Maria Vehreschild of the Universitätsklinikum Frankfurt has given some details in this talk
www.vimeo.com/873993707/description (from 32:30...
A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes
Sanderson, Theo; Hisner, Ryan; Donovan-Banfield, I’ah; Hartman, Hassan; Løchen, Alessandra; Peacock, Thomas P.; Ruis, Christopher
Molnupiravir, an antiviral medication that has been widely used against SARS-CoV-2, acts...
https://www.frontiersin.org/articles/10.3389/fmed.2022.1003103/full
Introduction: Long COVID, or post-acute sequelae of SARS-CoV-2 infection (PASC) in ∼30% of all infected individuals. Here, we present a case of PASC in a patient with rheumatoid arthritis characterized by viral persistence in...
Full title: The Artemisinin-Derived Autofluorescent Compound BG95 Exerts Strong Anticytomegaloviral Activity Based on a Mitochondrial Targeting Mechanism
Another paper examining virus-induced mitochondrial fragmentation/fission in this case by HCMV and effects of an artesunate-derived...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.